U.S. Markets close in 39 mins
  • S&P 500

    3,581.08
    +23.54 (+0.66%)
     
  • Dow 30

    29,620.03
    +356.55 (+1.22%)
     
  • Nasdaq

    11,898.34
    +43.37 (+0.37%)
     
  • Russell 2000

    1,785.34
    +1.21 (+0.07%)
     
  • Crude Oil

    42.17
    +0.43 (+1.03%)
     
  • Gold

    1,869.60
    +8.10 (+0.44%)
     
  • Silver

    24.23
    +0.18 (+0.74%)
     
  • EUR/USD

    1.1862
    -0.0014 (-0.1186%)
     
  • 10-Yr Bond

    0.8570
    +0.0280 (+3.38%)
     
  • Vix

    23.70
    +0.59 (+2.55%)
     
  • GBP/USD

    1.3291
    +0.0038 (+0.2858%)
     
  • USD/JPY

    103.8280
    +0.0570 (+0.0549%)
     
  • BTC-USD

    18,389.54
    -65.21 (-0.35%)
     
  • CMC Crypto 200

    363.61
    +2.18 (+0.60%)
     
  • FTSE 100

    6,351.45
    +17.10 (+0.27%)
     
  • Nikkei 225

    25,527.37
    -106.93 (-0.42%)
     

LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020

BURLINGTON, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (LMAT) announced today that David Roberts, President, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at the Lotte New York Palace Hotel in New York City.

The Company is scheduled to present at 10:00 a.m. EST.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.

Contact:
LeMaitre Vascular, Inc.
Sandra Millar
+1-781-425-1686
smillar@lemaitre.com